← Insider buys
AGIO

Agios Pharmaceuticals, Inc. · Healthcare

Chief Commercial Officer Tsveta Milanova sold $65K of Agios Pharmaceuticals, Inc.

Sold$64,773
$22.32Price
2,902Shares
−24%Stake

What AGIO did after the filing

Filed Jan 5Copier in Jan 8
The stock from Mon, Jan 8 open, $23.04
+16.3%
S&P 500, same days
+6.1%

Measured over 30 trading days, to the Feb 21 close.

Traded Fri, Jan 5. Filed Fri, Jan 5, 4:10 PM ET, after the close. Returns use the Jan 8 open and the Feb 21 close. Not investment advice.